{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:34:35Z","timestamp":1787668475388,"version":"build-2736575974"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T00:00:00Z","timestamp":1542931200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"This study was conducted in part at the Joint Usage \/ Research Center on Tropical Disease, Institute of Tropical Medicine, Nagasaki University."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s00431-018-3287-7","type":"journal-article","created":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T12:34:20Z","timestamp":1542976460000},"page":"301-314","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Association between exposure to macrolides and the development of infantile hypertrophic pyloric stenosis: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"178","author":[{"given":"Mohammed","family":"Abdellatif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherief","family":"Ghozy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Gomaa","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameh Samir","family":"Elawady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Mohy Eldeen","family":"Ghorab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew Wassef","family":"Attia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Truong Thi","family":"Le Huyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diep Trong Vien","family":"Duy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Hirayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Tien","family":"Huy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,23]]},"reference":[{"key":"3287_CR1","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1001\/archpedi.1995.02170230077011","volume":"149","author":"MS Applegate","year":"1995","unstructured":"Applegate MS, Druschel CM (1995) The epidemiology of infantile hypertrophic pyloric stenosis in New York State: 1983 to 1990. Arch Pediatr Adolesc Med 149:1123\u20131129","journal-title":"Arch Pediatr Adolesc Med"},{"key":"3287_CR2","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.1128\/AAC.01691-12","volume":"57","author":"A Bahat Dinur","year":"2013","unstructured":"Bahat Dinur A, Koren G, Matok I, Wiznitzer A, Uziel E, Gorodischer R, Levy A (2013) Fetal safety of macrolides. Antimicrob Agents Chemother 57:3307\u20133311","journal-title":"Antimicrob Agents Chemother"},{"key":"3287_CR3","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.2307\/2533446","volume":"50","author":"CB Begg","year":"1994","unstructured":"Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088\u20131101","journal-title":"Biometrics"},{"key":"3287_CR4","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1111\/bph.12077","volume":"168","author":"J Broad","year":"2013","unstructured":"Broad J, Sanger GJ (2013) The antibiotic azithromycin is a motilin receptor agonist in human stomach: comparison with erythromycin. Br J Pharmacol 168:1859\u20131867","journal-title":"Br J Pharmacol"},{"key":"3287_CR5","first-page":"1117","volume":"48","author":"Centers for Disease Control Prevention","year":"1999","unstructured":"Centers for Disease Control Prevention (1999) Hypertrophic pyloric stenosis in infants following pertussis prophylaxis with erythromycin--Knoxville, Tennessee, 1999. MMWR Morb Mortal Wkly Rep 48:1117","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"3287_CR6","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.annemergmed.2011.04.006","volume":"58","author":"Centers for Disease Control Prevention","year":"2011","unstructured":"Centers for Disease Control Prevention (2011) Sexually transmitted diseases treatment guidelines, 2010. Ann Emerg Med 58:67\u201368","journal-title":"Ann Emerg Med"},{"key":"3287_CR7","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1001\/archpedi.156.7.647","volume":"156","author":"WO Cooper","year":"2002","unstructured":"Cooper WO, Griffin MR, Arbogast P, Hickson GB, Gautam S, Ray WA (2002) Very early exposure to erythromycin and infantile hypertrophic pyloric stenosis. Arch Pediatr Adolesc Med 156:647\u2013650","journal-title":"Arch Pediatr Adolesc Med"},{"key":"3287_CR8","first-page":"101","volume":"100","author":"WO Cooper","year":"2002","unstructured":"Cooper WO, Ray WA, Griffin MR (2002) Prenatal prescription of macrolide antibiotics and infantile hypertrophic pyloric stenosis. Obstet Gynecol 100:101\u2013106","journal-title":"Obstet Gynecol"},{"key":"3287_CR9","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1001\/archpediatrics.2009.188","volume":"163","author":"KS Crider","year":"2009","unstructured":"Crider KS, Cleves MA, Reefhuis J, Berry RJ, Hobbs CA, Hu DJ (2009) Antibacterial medication use during pregnancy and risk of birth defects: National Birth Defects Prevention Study. Arch Pediatr Adolesc Med 163:978\u2013985","journal-title":"Arch Pediatr Adolesc Med"},{"key":"3287_CR10","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","volume":"56","author":"S Duval","year":"2000","unstructured":"Duval S, Tweedie R (2000) Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56:455\u2013463","journal-title":"Biometrics"},{"key":"3287_CR11","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1542\/peds.2014-2026","volume":"135","author":"MD Eberly","year":"2015","unstructured":"Eberly MD, Eide MB, Thompson JL, Nylund CM (2015) Azithromycin in early infancy and pyloric stenosis. Pediatrics 135:483\u2013488","journal-title":"Pediatrics"},{"key":"3287_CR12","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629\u2013634","journal-title":"BMJ"},{"key":"3287_CR13","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/MPG.0000000000000792","volume":"61","author":"JE Ericson","year":"2015","unstructured":"Ericson JE, Arnold C, Cheeseman J, Cho J, Kaneko S, Clark RH, Benjamin DK Jr, Chu V, Smith PB, Hornik CP (2015) Use and safety of erythromycin and metoclopramide in hospitalized infants. J Pediatr Gastroenterol Nutr 61:334\u2013339","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"3287_CR14","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1086\/502328","volume":"25","author":"DS Friedman","year":"2004","unstructured":"Friedman DS, Curtis CR, Schauer SL, Salvi S, Klapholz H, Treadwell T, Wortzman J, Bisgard KM, Lett SM (2004) Surveillance for transmission and antibiotic adverse events among neonates and adults exposed to a healthcare worker with pertussis. Infect Control Hosp Epidemiol 25:967\u2013973","journal-title":"Infect Control Hosp Epidemiol"},{"key":"3287_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2288-7-5","volume":"7","author":"JO Friedrich","year":"2007","unstructured":"Friedrich JO, Adhikari NK, Beyene J (2007) Inclusion of zero total event trials in meta-analyses maintains analytic consistency and incorporates all available data. BMC Med Res Methodol 7:1","journal-title":"BMC Med Res Methodol"},{"key":"3287_CR16","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1089\/bfm.2008.0135","volume":"4","author":"L Goldstein","year":"2009","unstructured":"Goldstein L, Berlin M, Tsur L, Bortnik O, Binyamini L, Berkovitch M (2009) The safety of macrolides during lactation. Breastfeed Med 4:197\u2013200","journal-title":"Breastfeed Med"},{"key":"3287_CR17","first-page":"395","volume":"140","author":"BF Habbick","year":"1989","unstructured":"Habbick BF, To T (1989) Incidence of infantile hypertrophic pyloric stenosis in Saskatchewan, 1970-85. CMAJ 140:395\u2013398","journal-title":"CMAJ"},{"key":"3287_CR18","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1136\/adc.85.5.379","volume":"85","author":"G Hedback","year":"2001","unstructured":"Hedback G, Abrahamsson K, Husberg B, Granholm T, Oden A (2001) The epidemiology of infantile hypertrophic pyloric stenosis in Sweden 1987-96. Arch Dis Child 85:379\u2013381","journal-title":"Arch Dis Child"},{"key":"3287_CR19","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1136\/ebmed-2014-110015","volume":"19","author":"MA Honein","year":"2014","unstructured":"Honein MA, Cragan JD (2014) Balancing competing risks: perinatal exposure to macrolides increases the risk of infantile hypertrophic pyloric stenosis. Evid Based Med 19:239","journal-title":"Evid Based Med"},{"key":"3287_CR20","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1016\/S0140-6736(99)10073-4","volume":"354","author":"M Honein","year":"1999","unstructured":"Honein M, Paulozzi L, Himelright I, Lee B, Cragan J, Patterson L, Correa A, Hall S, Erickson J (1999) Infantile hypertrophic pyloric stenosis after pertussis prophylaxis with erythromycin: a case review and cohort study. Lancet 354:2101\u20132105","journal-title":"Lancet"},{"key":"3287_CR21","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1203\/00006450-199709000-00018","volume":"42","author":"SR Jadcherla","year":"1997","unstructured":"Jadcherla SR, Klee G, Berseth CL (1997) Regulation of migrating motor complexes by motilin and pancreatic polypeptide in human infants. Pediatr Res 42:365\u2013369","journal-title":"Pediatr Res"},{"key":"3287_CR22","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.2174\/1381612043383322","volume":"10","author":"R Jain","year":"2004","unstructured":"Jain R, Danziger L (2004) The macrolide antibiotics: a pharmacokinetic and pharmacodynamic overview. Curr Pharm Des 10:3045\u20133053","journal-title":"Curr Pharm Des"},{"key":"3287_CR23","first-page":"334","volume":"142","author":"MB Jedd","year":"1988","unstructured":"Jedd MB, Melton LJ, Griffin MR, Kaufman B, Hoffman AD, Broughton D, O'Brien PC (1988) Factors associated with infantile hypertrophic pyloric stenosis. Am J Dis Child 142:334\u2013337","journal-title":"Am J Dis Child"},{"key":"3287_CR24","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.reprotox.2005.01.010","volume":"20","author":"BA K\u00e4ll\u00e9n","year":"2005","unstructured":"K\u00e4ll\u00e9n BA, Olausson PO, Danielsson BR (2005) Is erythromycin therapy teratogenic in humans? Reprod Toxicol 20:209\u2013214","journal-title":"Reprod Toxicol"},{"key":"3287_CR25","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1136\/heartjnl-2014-307293","volume":"101","author":"M Kowalewski","year":"2015","unstructured":"Kowalewski M, Schulze V, Berti S, Waksman R, Kubica J, Ko\u0142odziejczak M, Buffon A, Suryapranata H, Gurbel PA, Kelm M, Pawliszak W, Anisimowicz L, Navarese EP (2015) Complete revascularisation in ST-elevation myocardial infarction and multivessel disease: meta-analysis of randomised controlled trials. Heart 101:1309\u20131317","journal-title":"Heart"},{"key":"3287_CR26","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1001\/jama.2010.784","volume":"303","author":"C Krogh","year":"2010","unstructured":"Krogh C, Fischer TK, Skotte L, Biggar RJ, Oyen N, Skytthe A, Goertz S, Christensen K, Wohlfahrt J, Melbye M (2010) Familial aggregation and heritability of pyloric stenosis. Jama 303:2393\u20132399","journal-title":"Jama"},{"key":"3287_CR27","doi-asserted-by":"publisher","first-page":"W-65","DOI":"10.7326\/0003-4819-151-4-200908180-00136","volume":"151","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, G\u00f8tzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 151:W-65\u2013W-94","journal-title":"Ann Intern Med"},{"key":"3287_CR28","first-page":"221. e221","volume":"208","author":"KJ Lin","year":"2013","unstructured":"Lin KJ, Mitchell AA, Yau W-P, Louik C, Hern\u00e1ndez-D\u00edaz S (2013) Safety of macrolides during pregnancy. Am J Obstet Gynecol 208:221. e221\u2013221. e228","journal-title":"Am J Obstet Gynecol"},{"key":"3287_CR29","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1067\/mob.2002.119718","volume":"186","author":"C Louik","year":"2002","unstructured":"Louik C, Werler MM, Mitchell AA (2002) Erythromycin use during pregnancy in relation to pyloric stenosis. Am J Obstet Gynecol 186:288\u2013290","journal-title":"Am J Obstet Gynecol"},{"key":"3287_CR30","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s10654-015-0114-6","volume":"31","author":"JF Ludvigsson","year":"2016","unstructured":"Ludvigsson JF, Lundholm C, \u00d6rtqvist AK, Almqvist C (2016) No association between macrolide treatment in infancy and later pyloric stenosis in Sweden. Eur J Epidemiol 31:331\u2013332","journal-title":"Eur J Epidemiol"},{"key":"3287_CR31","doi-asserted-by":"publisher","first-page":"g1908","DOI":"10.1136\/bmj.g1908","volume":"348","author":"M Lund","year":"2014","unstructured":"Lund M, Pasternak B, Davidsen RB, Feenstra B, Krogh C, Diaz LJ, Wohlfahrt J, Melbye M (2014) Use of macrolides in mother and child and risk of infantile hypertrophic pyloric stenosis: nationwide cohort study. BMJ 348:g1908","journal-title":"BMJ"},{"key":"3287_CR32","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1067\/mpd.2001.117577","volume":"139","author":"BE Mahon","year":"2001","unstructured":"Mahon BE, Rosenman MB, Kleiman MB (2001) Maternal and infant use of erythromycin and other macrolide antibiotics as risk factors for infantile hypertrophic pyloric stenosis. J Pediatr 139:380\u2013384","journal-title":"J Pediatr"},{"key":"3287_CR33","first-page":"281","volume":"2","author":"JM McGuire","year":"1952","unstructured":"McGuire JM, Bunch R, Anderson R, Boaz H, Flynn E, Powell H, Smith J (1952) Ilotycin, a new antibiotic. Antibiot Chemother 2:281\u2013283","journal-title":"Antibiot Chemother"},{"key":"3287_CR34","doi-asserted-by":"publisher","first-page":"51. e51","DOI":"10.1016\/j.ajog.2011.02.029","volume":"205","author":"AA Mitchell","year":"2011","unstructured":"Mitchell AA, Gilboa SM, Werler MM, Kelley KE, Louik C, Hern\u00e1ndez-D\u00edaz S, Study National Birth Defects Prevention (2011) Medication use during pregnancy, with particular focus on prescription drugs: 1976\u20132008. Am J Obstet Gynecol 205:51. e51\u201351. e58","journal-title":"Am J Obstet Gynecol"},{"key":"3287_CR35","first-page":"952","volume":"51","author":"M Mohammadizadeh","year":"2010","unstructured":"Mohammadizadeh M, Ghazinour M, Iranpour R (2010) Efficacy of prophylactic oral erythromycin to improve enteral feeding tolerance in preterm infants: a randomised controlled study. Singap Med J 51:952","journal-title":"Singap Med J"},{"key":"3287_CR36","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/01.inf.0000253063.87338.60","volume":"26","author":"W Morrison","year":"2007","unstructured":"Morrison W (2007) Infantile hypertrophic pyloric stenosis in infants treated with azithromycin. Pediatr Infect Dis J 26:186\u2013188","journal-title":"Pediatr Infect Dis J"},{"key":"3287_CR37","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1007\/s00383-016-3971-5","volume":"32","author":"L Murchison","year":"2016","unstructured":"Murchison L, De Coppi P, Eaton S (2016) Post-natal erythromycin exposure and risk of infantile hypertrophic pyloric stenosis: a systematic review and meta-analysis. Pediatr Surg Int 32:1147\u20131152","journal-title":"Pediatr Surg Int"},{"key":"3287_CR38","unstructured":"National Institutes of Health (2014) National Blood Lung and Heart Insititute. Quality assessment of controlled intervention studies. 2014. Avaliable: \n                    http:\/\/www.nhlbi.nih.gov\/health-pro\/guidelines\/in-develop\/cardiovascular-risk-reduction\/tools\/rct"},{"key":"3287_CR39","unstructured":"National Institutes of Health (2014) Quality assessment tool for observational cohort and cross-sectional studies. National Heart, Lung, and Blood Institute Avaliable from: www nhlbi nih gov\/health-pro\/guidelines\/in-develop\/cardiovascular-risk-reduction\/tools\/cohort [Accessed November 5, 2015]"},{"key":"3287_CR40","doi-asserted-by":"publisher","first-page":"F177","DOI":"10.1136\/fn.84.3.F177","volume":"84","author":"P Ng","year":"2001","unstructured":"Ng P, So K, Fung K, Lee C, Fok T, Wong E, Wong W, Cheung K, Cheng A (2001) Randomised controlled study of oral erythromycin for treatment of gastrointestinal dysmotility in preterm infants. Arch Dis Child Fetal Neonatal Ed 84:F177\u2013F182","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"3287_CR41","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ijcard.2017.06.027","volume":"244","author":"AV Nguyen","year":"2017","unstructured":"Nguyen AV, Thanh LV, Kamel MG, Abdelrahman SAM, El-Mekawy M, Mokhtar MA, Ali AA, Hoang NNN, Vuong NL, Abd-Elhay FA, Omer OA, Mohamed AA, Hirayama K, Huy NT (2017) Optimal percutaneous coronary intervention in patients with ST-elevation myocardial infarction and multivessel disease: an updated, large-scale systematic review and meta-analysis. Int J Cardiol 244:67\u201376","journal-title":"Int J Cardiol"},{"key":"3287_CR42","doi-asserted-by":"publisher","first-page":"G470","DOI":"10.1152\/ajpgi.1989.257.3.G470","volume":"257","author":"T Peeters","year":"1989","unstructured":"Peeters T, Matthijs G, Depoortere I, Cachet T, Hoogmartens J, Vantrappen G (1989) Erythromycin is a motilin receptor agonist. Am J Physiol Gastrointest Liver Physiol 257:G470\u2013G474","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"3287_CR43","first-page":"137","volume":"11","author":"S Piscitelli","year":"1992","unstructured":"Piscitelli S, Danziger LH, Rodvold KA (1992) Clarithromycin and azithromycin: new macrolide antibiotics. Clin Pharm 11:137\u2013152","journal-title":"Clin Pharm"},{"key":"3287_CR44","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.yapd.2011.03.005","volume":"58","author":"JD Ranells","year":"2011","unstructured":"Ranells JD, Carver JD, Kirby RS (2011) Infantile hypertrophic pyloric stenosis: epidemiology, genetics, and clinical update. Adv Pediatr 58:195\u2013206","journal-title":"Adv Pediatr"},{"key":"3287_CR45","doi-asserted-by":"publisher","first-page":"392010","DOI":"10.1155\/2013\/392010","volume":"2013","author":"V Rivulgo","year":"2013","unstructured":"Rivulgo V, Sparo M, Ceci M, Fumuso E, Confalonieri A, Delpech G, Bruni SF (2013) Comparative plasma exposure and lung distribution of two human use commercial azithromycin formulations assessed in murine model: a preclinical study. Biomed Res Int 2013:392010","journal-title":"Biomed Res Int"},{"key":"3287_CR46","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1128\/AAC.02668-15","volume":"60","author":"S Salman","year":"2016","unstructured":"Salman S, Davis TM, Page-Sharp M, Camara B, Oluwalana C, Bojang A, D'Alessandro U, Roca A (2016) Pharmacokinetics of transfer of azithromycin into the breast milk of African mothers. Antimicrob Agents Chemother 60:1592\u20131599","journal-title":"Antimicrob Agents Chemother"},{"key":"3287_CR47","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0022-3468(76)90283-9","volume":"11","author":"JA SanFilippo","year":"1976","unstructured":"SanFilippo JA (1976) Infantile hypertrophic pyloric stenosis related to ingestion of erythromycine estolate: a report of five cases. J Pediatr Surg 11:177\u2013180","journal-title":"J Pediatr Surg"},{"key":"3287_CR48","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1046\/j.1365-3016.1997.d01-32.x","volume":"11","author":"R Schechter","year":"1997","unstructured":"Schechter R, Torfs CP, Bateson TF (1997) The epidemiology of infantile hypertrophic pyloric stenosis. Paediatr Perinat Epidemiol 11:407\u2013427","journal-title":"Paediatr Perinat Epidemiol"},{"key":"3287_CR49","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1136\/adc.2007.128090","volume":"93","author":"T Sommerfield","year":"2008","unstructured":"Sommerfield T, Chalmers J, Youngson G, Heeley C, Fleming M, Thomson G (2008) The changing epidemiology of infantile hypertrophic pyloric stenosis in Scotland. Arch Dis Child 93:1007\u20131011","journal-title":"Arch Dis Child"},{"key":"3287_CR50","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1080\/0036554021000027010","volume":"35","author":"HT S\u00f8rensen","year":"2003","unstructured":"S\u00f8rensen HT, Skriver MV, Pedersen L, Larsen H, Ebbesen F, Sch\u00f8nheyder HC (2003) Risk of infantile hypertrophic pyloric stenosis after maternal postnatal use of macrolides. Scand J Infect Dis 35:104\u2013106","journal-title":"Scand J Infect Dis"},{"key":"3287_CR51","first-page":"669","volume":"69","author":"H Stang","year":"1986","unstructured":"Stang H (1986) Pyloric stenosis associated with erythromycin ingested through breastmilk. Minn Med 69:669","journal-title":"Minn Med"},{"key":"3287_CR52","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1046\/j.1365-3016.2001.00366.x","volume":"15","author":"ST Sule","year":"2001","unstructured":"Sule ST, Stone DH, Gilmour H (2001) The epidemiology of infantile hypertrophic pyloric stenosis in greater Glasgow area, 1980-96. Paediatr Perinat Epidemiol 15:379\u2013380","journal-title":"Paediatr Perinat Epidemiol"},{"key":"3287_CR53","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3102\/1076998609346961","volume":"35","author":"JC Valentine","year":"2010","unstructured":"Valentine JC, Pigott TD, Rothstein HR (2010) How many studies do you need? A primer on statistical power for meta-analysis. J Educ Behav Stat 35:215\u2013247","journal-title":"J Educ Behav Stat"},{"key":"3287_CR54","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1182\/blood-2008-01-130500","volume":"112","author":"JL Wynn","year":"2008","unstructured":"Wynn JL, Scumpia PO, Winfield RD, Delano MJ, Kelly-Scumpia K, Barker T, Ungaro R, Levy O, Moldawer LL (2008) Defective innate immunity predisposes murine neonates to poor sepsis outcome but is reversed by TLR agonists. Blood 112:1750\u20131758","journal-title":"Blood"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00431-018-3287-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-018-3287-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-018-3287-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T00:15:35Z","timestamp":1574468135000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00431-018-3287-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,23]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["3287"],"URL":"https:\/\/doi.org\/10.1007\/s00431-018-3287-7","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,23]]},"assertion":[{"value":"13 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}